This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jan;12(1):6-8.

doi: 10.1016/S1470-2045(10)70271-0. Epub 2010 Nov 29.

Blood-pressure drugs and cancer: much ado about nothing?

Lars H Lindholm¹, Bo Carlberg

Affiliations

PMID: 21123112
DOI: 10.1016/S1470-2045(10)70271-0

Comment

Blood-pressure drugs and cancer: much ado about nothing?

Lars H Lindholm et al. Lancet Oncol. 2011 Jan.

. 2011 Jan;12(1):6-8.

doi: 10.1016/S1470-2045(10)70271-0. Epub 2010 Nov 29.

Authors

Lars H Lindholm¹, Bo Carlberg

Affiliation

¹ Department of Public Health and Clinical Medicine, Umeå University, SE 90185 Umeå, Sweden. larsh.lindholm@fammed.umu.se

PMID: 21123112
DOI: 10.1016/S1470-2045(10)70271-0

No abstract available

PubMed Disclaimer

Comment on

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH. Bangalore S, et al. Lancet Oncol. 2011 Jan;12(1):65-82. doi: 10.1016/S1470-2045(10)70260-6. Epub 2010 Nov 29. Lancet Oncol. 2011. PMID: 21123111

Similar articles

[Antihypertensive therapy].
Schmieder RE, Veelken R. Schmieder RE, et al. MMW Fortschr Med. 2009 Apr 2;151(14):95-8; quiz 99. MMW Fortschr Med. 2009. PMID: 19504848 German. No abstract available.
[Is one antihypertensive agent as good as another?].
Trenkwalder P. Trenkwalder P. MMW Fortschr Med. 2002 Nov 7;144(45):41-2. MMW Fortschr Med. 2002. PMID: 12534060 German. No abstract available.
[Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
Dominiak P. Dominiak P. MMW Fortschr Med. 2004 Dec 16;146(51-52):51. MMW Fortschr Med. 2004. PMID: 15675248 German. No abstract available.
Review of the international literature on isradipine in hypertension (Lomir/Dynacirc).
Soland FX. Soland FX. Cor Vasa. 1990;32(2 Suppl 1):61-72. Cor Vasa. 1990. PMID: 2143461 Review. No abstract available.
[Use of angiotensin-II-antagonists in hypertension].
Birkenhäger WH, de Leeuw PW. Birkenhäger WH, et al. Ned Tijdschr Geneeskd. 2000 Jul 15;144(29):1397-402. Ned Tijdschr Geneeskd. 2000. PMID: 10923148 Review. Dutch.

See all similar articles

Cited by

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
Roe MT, Cyr DD, Eckart D, Schulte PJ, Morse MA, Blackwell KL, Ready NE, Zafar SY, Beaven AW, Strickler JH, Onken JE, Winters KJ, Houterloot L, Zamoryakhin D, Wiviott SD, White HD, Prabhakaran D, Fox KA, Armstrong PW, Ohman EM; TRILOGY ACS Investigators. Roe MT, et al. Eur Heart J. 2016 Jan 21;37(4):412-22. doi: 10.1093/eurheartj/ehv611. Epub 2015 Dec 5. Eur Heart J. 2016. PMID: 26637834 Free PMC article. Clinical Trial.
Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.
Yoon C, Yang HS, Jeon I, Chang Y, Park SM. Yoon C, et al. CMAJ. 2011 Oct 4;183(14):E1073-84. doi: 10.1503/cmaj.101497. Epub 2011 Aug 29. CMAJ. 2011. PMID: 21876027 Free PMC article.
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies.
Shin K, Yang J, Yu Y, Son E, Kim K, Kim YH. Shin K, et al. Ther Adv Drug Saf. 2022 Oct 10;13:20420986221129335. doi: 10.1177/20420986221129335. eCollection 2022. Ther Adv Drug Saf. 2022. PMID: 36249084 Free PMC article.
The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors.
Mo M, Thiesmeier R, Kiwango G, Rausch C, Möller J, Liang Y. Mo M, et al. J Cardiovasc Dev Dis. 2023 Oct 15;10(10):426. doi: 10.3390/jcdd10100426. J Cardiovasc Dev Dis. 2023. PMID: 37887873 Free PMC article.
The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis.
Liao WC, Shokr H, Faivre-Finn C, Dempsey C, Williams KJ, Chen LC. Liao WC, et al. Pharmaceuticals (Basel). 2025 Jan 16;18(1):105. doi: 10.3390/ph18010105. Pharmaceuticals (Basel). 2025. PMID: 39861167 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information